The role of FDG-PET/CT in monitoring and detection of residual disease in patients with urinary bladder carcinoma

Introduction: Urinary bladder carcinoma is the ninth most common cancer in the world. Recurrence rate for this disease is very high. 18F-FDG/PET is a very important diagnostic tool in clinical monitoring of patients with bladder carcinoma. FDG-PET/CT was proved to be superior to computed tomography (CT) and magnetic resonance imagining (MRI) in evaluating the nature of active lesions and in the detecting site of disease recurrence. Additionally, it is useful in the primary staging of the disease.